158 related articles for article (PubMed ID: 19620774)
21. The calcineurin-NFAT-angiopoietin-2 signaling axis in lung endothelium is critical for the establishment of lung metastases.
Minami T; Jiang S; Schadler K; Suehiro J; Osawa T; Oike Y; Miura M; Naito M; Kodama T; Ryeom S
Cell Rep; 2013 Aug; 4(4):709-23. PubMed ID: 23954784
[TBL] [Abstract][Full Text] [Related]
22. Differential functions of genes regulated by VEGF-NFATc1 signaling pathway in the migration of pulmonary valve endothelial cells.
Jang GH; Park IS; Yang JH; Bischoff J; Lee YM
FEBS Lett; 2010 Jan; 584(1):141-6. PubMed ID: 19914243
[TBL] [Abstract][Full Text] [Related]
23. Direct biomechanical induction of endogenous calcineurin inhibitor Down Syndrome Critical Region-1 in cardiac myocytes.
Wang Y; De Keulenaer GW; Weinberg EO; Muangman S; Gualberto A; Landschulz KT; Turi TG; Thompson JF; Lee RT
Am J Physiol Heart Circ Physiol; 2002 Aug; 283(2):H533-9. PubMed ID: 12124198
[TBL] [Abstract][Full Text] [Related]
24. Arsenic Trioxide Inhibits the Metastasis of Small Cell Lung Cancer by Blocking Calcineurin-Nuclear Factor of Activated T Cells (NFAT) Signaling.
Zheng JC; Chang KJ; Jin YX; Zhao XW; Li B; Yang MH
Med Sci Monit; 2019 Mar; 25():2228-2237. PubMed ID: 30913205
[TBL] [Abstract][Full Text] [Related]
25. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1.
Baek KH; Zaslavsky A; Lynch RC; Britt C; Okada Y; Siarey RJ; Lensch MW; Park IH; Yoon SS; Minami T; Korenberg JR; Folkman J; Daley GQ; Aird WC; Galdzicki Z; Ryeom S
Nature; 2009 Jun; 459(7250):1126-30. PubMed ID: 19458618
[TBL] [Abstract][Full Text] [Related]
26. Requirement of the nuclear localization of transcription enhancer factor 3 for proliferation, migration, tube formation, and angiogenesis induced by vascular endothelial growth factor.
Liu X; Zhao D; James L; Li J; Zeng H
FASEB J; 2011 Apr; 25(4):1188-97. PubMed ID: 21169383
[TBL] [Abstract][Full Text] [Related]
27. Secretion of Down Syndrome Critical Region 1 Isoform 4 in Ischemic Retinal Ganglion Cells Displays Anti-Angiogenic Properties Via NFATc1-Dependent Pathway.
Xu Y; Yang B; Hu Y; Lu L; Lu X; Wang J; Shu Q; Cheng Q; Yu S; Xu F; Huang J; Liang X
Mol Neurobiol; 2017 Oct; 54(8):6556-6571. PubMed ID: 27734335
[TBL] [Abstract][Full Text] [Related]
28. NFATc1 regulates lymphatic endothelial development.
Kulkarni RM; Greenberg JM; Akeson AL
Mech Dev; 2009; 126(5-6):350-65. PubMed ID: 19233265
[TBL] [Abstract][Full Text] [Related]
29. Calcineurin-Rcan1 interaction contributes to stem cell factor-mediated mast cell activation.
Wu Z; Li Y; MacNeil AJ; Junkins RD; Berman JN; Lin TJ
J Immunol; 2013 Dec; 191(12):5885-94. PubMed ID: 24218457
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease.
Hartmann D; Fiedler J; Sonnenschein K; Just A; Pfanne A; Zimmer K; Remke J; Foinquinos A; Butzlaff M; Schimmel K; Maegdefessel L; Hilfiker-Kleiner D; Lachmann N; Schober A; Froese N; Heineke J; Bauersachs J; Batkai S; Thum T
Circulation; 2016 Dec; 134(24):1973-1990. PubMed ID: 27780851
[TBL] [Abstract][Full Text] [Related]
31. Regulator of calcineurin 1 controls growth plasticity of adult pancreas.
Gurda GT; Crozier SJ; Ji B; Ernst SA; Logsdon CD; Rothermel BA; Williams JA
Gastroenterology; 2010 Aug; 139(2):609-19, 619.e1-6. PubMed ID: 20438729
[TBL] [Abstract][Full Text] [Related]
32. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1.
Takeda N; Maemura K; Imai Y; Harada T; Kawanami D; Nojiri T; Manabe I; Nagai R
Circ Res; 2004 Jul; 95(2):146-53. PubMed ID: 15192019
[TBL] [Abstract][Full Text] [Related]
33. Trisomy of the Dscr1 gene suppresses early progression of pancreatic intraepithelial neoplasia driven by oncogenic Kras.
Lee JC; Shin J; Baek KH
Biochem Biophys Res Commun; 2013 Oct; 440(1):50-5. PubMed ID: 24041692
[TBL] [Abstract][Full Text] [Related]
34. Differential roles for ETS, CREB, and EGR binding sites in mediating VEGF receptor 1 expression in vivo.
Jin E; Liu J; Suehiro J; Yuan L; Okada Y; Nikolova-Krstevski V; Yano K; Janes L; Beeler D; Spokes KC; Li D; Regan E; Shih SC; Oettgen P; Minami T; Aird WC
Blood; 2009 Dec; 114(27):5557-66. PubMed ID: 19822898
[TBL] [Abstract][Full Text] [Related]
35. Rcan1 negatively regulates Fc epsilonRI-mediated signaling and mast cell function.
Yang YJ; Chen W; Edgar A; Li B; Molkentin JD; Berman JN; Lin TJ
J Exp Med; 2009 Jan; 206(1):195-207. PubMed ID: 19124655
[TBL] [Abstract][Full Text] [Related]
36. The CCAAT/enhancer binding protein beta (C/EBPbeta) cooperates with NFAT to control expression of the calcineurin regulatory protein RCAN1-4.
Oh M; Dey A; Gerard RD; Hill JA; Rothermel BA
J Biol Chem; 2010 May; 285(22):16623-31. PubMed ID: 20371871
[TBL] [Abstract][Full Text] [Related]
37. A three-kilobase fragment of the human Robo4 promoter directs cell type-specific expression in endothelium.
Okada Y; Yano K; Jin E; Funahashi N; Kitayama M; Doi T; Spokes K; Beeler DL; Shih SC; Okada H; Danilov TA; Maynard E; Minami T; Oettgen P; Aird WC
Circ Res; 2007 Jun; 100(12):1712-22. PubMed ID: 17495228
[TBL] [Abstract][Full Text] [Related]
38. Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth.
Ryeom S; Baek KH; Rioth MJ; Lynch RC; Zaslavsky A; Birsner A; Yoon SS; McKeon F
Cancer Cell; 2008 May; 13(5):420-31. PubMed ID: 18455125
[TBL] [Abstract][Full Text] [Related]
39. Vascular bed-specific regulation of the von Willebrand factor promoter in the heart and skeletal muscle.
Liu J; Yuan L; Molema G; Regan E; Janes L; Beeler D; Spokes KC; Okada Y; Minami T; Oettgen P; Aird WC
Blood; 2011 Jan; 117(1):342-51. PubMed ID: 20980682
[TBL] [Abstract][Full Text] [Related]
40. DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways.
Fuentes JJ; Genescà L; Kingsbury TJ; Cunningham KW; Pérez-Riba M; Estivill X; de la Luna S
Hum Mol Genet; 2000 Jul; 9(11):1681-90. PubMed ID: 10861295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
